Form 8-K - Current report:
SEC Accession No. 0001104659-24-130156
Filing Date
2024-12-19
Accepted
2024-12-19 16:05:43
Documents
15
Period of Report
2024-12-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2431481d1_8k.htm   iXBRL 8-K 30062
2 EXHIBIT 99.1 tm2431481d1_ex99-1.htm EX-99.1 66638
6 GRAPHIC tm2431481d1_ex99-1img001.jpg GRAPHIC 3225
  Complete submission text file 0001104659-24-130156.txt   294661

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxs-20241217.xsd EX-101.SCH 3018
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20241217_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20241217_pre.xml EX-101.PRE 22361
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2431481d1_8k_htm.xml XML 3691
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 241563320
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)